Use of biologic treatment in psoriasis patients with HIV: A systematic review
- PMID: 38452816
- DOI: 10.1016/j.jaad.2024.02.042
Use of biologic treatment in psoriasis patients with HIV: A systematic review
Keywords: AIDS; HIV; biologics; evidence-based; immunocompromised; psoriasis; systematic review.
Conflict of interest statement
Conflicts of interest Dr Yeung has been an advisor, consultant, speaker, and/or investigator for AbbVie, Allergan, Amgen, Astellas, Bausche, Baxalta, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Fresenius Kabi, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Medimmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sun Pharma, Takeda, UCB, and Xenon. Dr Mufti has been a speaker for AbbVie and Janssen. Authors Sood, Geng, and Heung have no conflicts of interest to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical